ArticleScientific reports2025

Cytogenetic risk stratification combined with minimal residual disease status influences the therapeutic outcome and prognosis of multiple myelomas.

Jianping Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.